Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on
“Cowabunga! Riding Breast Cancer’s Biggest Data’s Wave from Literature
Our new study on HER2-low luminal BC is making waves!
566 patients showed tricky patterns: lower pCR rates (13.2% vs 17.7%) but trending toward better survival for HER2-low.”
Authors: Giovanna Garufi, Armando Orlandi et al
